Gene · 3145
Papers3,427
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,427
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unveiling the Role of the Proton Gateway, Uncoupling Proteins (UCPs), in Cancer Cachexia. | Cancers (Basel) | 2023 | 36900198 | PubTator, text mining | PubMed |
| Downregulation of Dystrophin Expression Occurs across Diverse Tumors, Correlates with the Age of Onset, Staging and Reduced Survival of Patients. | Cancers (Basel) | 2023 | 36900171 | PubTator, text mining | PubMed |
| Performance Characteristics of Oncomine Focus Assay for Theranostic Analysis of Solid Tumors, A (21-Months) Real-Life Study. | Diagnostics (Basel) | 2023 | 36900081 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Nemorosone-Induced Ferroptosis in Cancer Cells. | Cells | 2023 | 36899871 | PubTator, text mining | PubMed |
| Brazilian registry of patients with porphyria: REBRAPPO study. | Orphanet J Rare Dis | 2023 | 36890577 | PubTator, text mining | PubMed |
Unveiling the therapeutic potential of cabozantinib-loaded poly D,L-lactic-co-glycolic acid and polysarcosine nanoparticles in inducing apoptosis and cytotoxicity in human HepG2 hepatocellular carcinoma cell lines and in vivo anti-tumor activity in SCID female mice. | Front Oncol | 2023 | 36874145 | PubTator, text mining | PubMed |
| Recurrent symptoms of acute intermittent porphyria after biochemical normalization with givosiran-An ongoing clinical conundrum. | JIMD Rep | 2023 | 36873084 | PubTator, text mining | PubMed |
| Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer. | Cancer Discov | 2023 | 36862804 | PubTator, text mining | PubMed |
| Systemic inflammatory markers in patients with polyneuropathies. | Front Immunol | 2023 | 36860843 | PubTator, text mining | PubMed |
| Fine particulate matter (PM2.5)-induced pulmonary oxidative stress contributes to changes in the plasma lipidome and liver transcriptome in mice. | Toxicol Sci | 2023 | 36857595 | PubTator, text mining | PubMed |
| Genetic Susceptibility to Hepatocellular Carcinoma in Patients with Chronic Hepatitis Virus Infection. | Viruses | 2023 | 36851773 | PubTator, text mining | PubMed |
| Screening the Pathogen Box to Discover and Characterize New Cruzain and TbrCatL Inhibitors. | Pathogens | 2023 | 36839523 | PubTator, text mining | PubMed |
| Genome-wide association study of the age of onset of type 1 diabetes reveals HTATIP2 as a novel T cell regulator. | Front Immunol | 2023 | 36817429 | PubTator, text mining | PubMed |
| Validation of the Reference Genes for Expression Analysis in the Hippocampus after Transient Ischemia/Reperfusion Injury in Gerbil Brain. | Int J Mol Sci | 2023 | 36769080 | PubTator, text mining | PubMed |
| To Kill or to Be Killed: How Does the Battle between the UPS and Autophagy Maintain the Intracellular Homeostasis in Eukaryotes? | Int J Mol Sci | 2023 | 36768543 | PubTator, text mining | PubMed |
| Impact of Plasticizer on the Intestinal Epithelial Integrity and Tissue-Repairing Ability within Cells in the Proximity of the Human Gut Microbiome. | Int J Environ Res Public Health | 2023 | 36767519 | PubTator, text mining | PubMed |
| Downregulation of the Autism Spectrum Disorder Gene Shank2 Decreases Bone Mass in Male Mice. | JBMR Plus | 2023 | 36751416 | PubTator, text mining | PubMed |
| Targeting cyclin-dependent kinases in sarcoma treatment: Current perspectives and future directions. | Front Oncol | 2023 | 36741019 | PubTator, text mining | PubMed |
| A whole-genome scan for Artemisinin cytotoxicity reveals a novel therapy for human brain tumors. | EMBO Mol Med | 2023 | 36740985 | PubTator, text mining | PubMed |
| The Ubiquitin Proteasome System as a Therapeutic Area in Parkinson's Disease. | Neuromolecular Med | 2023 | 36739586 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3145/papers?page=17